The detection of fibrosis within nonalcoholic fatty liver disease (NAFLD) is important for
ascertaining prognosis and the stratification of patients for emerging therapeutic intervention. We …

Objectives To evaluate the existing evidence for associations between coffee consumption
and multiple health outcomes. Design Umbrella review of the evidence across meta-analyses …

Background Clinicians use fibrosis in a liver biopsy to predict clinical outcomes of chronic
liver disease. The performance of non-invasive tests has been evaluated against histological …

Background & Aims The development of non-invasive liver fibrosis tests may enable earlier
identification of patients with non-alcoholic fatty liver disease (NAFLD) requiring referral to …

BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) is the most frequent
chronic liver disease in children and adolescents in industrialized countries. It is important to …

BACKGROUND/AIMS: Chronic hepatitis C (CHC) is characterised by hepatic fibrosis, used
as a proxy measure of prognosis. Liver biopsy is a flawed reference standard and serum …

Background Critical appraisal is the process of assessing and interpreting evidence by
systematically considering its validity, results and relevance to an individual's work. Within the …

Primary biliary cirrhosis (PBC) is sometimes diagnosed based on a positive antimitochondrial
antibody in the appropriate clinical setting without a liver biopsy. Although a liver biopsy …

Background FibroTest (FT) is the most frequently used serum fibrosis marker and consists of
an algorithm of five fibrosis markers (alfa2-macroglobulin, apolipoproteinA1, haptoglobin, …

Objective To examine the extent, nature and quality of literature on the impact of the COVID-19
pandemic on the mental health of imprisoned people and prison staff. Design Scoping …